Curaleaf Files Formal Update Increasing Offer to Acquire Aurora Cannabis
Curaleaf has updated its offer to acquire Aurora Cannabis, proposing $5 per share (0.4013 shares + $1 cash) and raising the max to $6. This represents an 86% premium over Aurora's 30-day average. Curaleaf urges Aurora to engage in discussions and has addressed technical issues raised by Aurora. The deal, if completed, would merge two major cannabis companies.
How this was made

The 30-second read
Why it matters
The enhanced offer represents a significant premium and may reshape market dynamics in the cannabis sector.
Market read
First report of a materially increased M&A proposal in the cannabis industry, likely to move both stocks and affect sector sentiment.
What to watch
Regulatory approvals in both jurisdictions and integration risks may delay or derail the transaction.
Background
Curaleaf and Aurora Cannabis are two of the largest publicly traded cannabis companies, with Curaleaf listed in the U.S. and Aurora on the Toronto Stock Exchange.
Market effects
Consolidation in the cannabis sector could pressure peers' valuations and spur further M&A activity.
U.S. and Canadian cannabis markets may see increased investor interest following the cross‑border deal.
The transaction highlights growing international integration of the cannabis industry.
Counterpoint
The deal could dilute Curaleaf's earnings per share and increase debt, weighing on its stock.
Key entities
- CompanyCuraleaf Holdings
U.S.-listed cannabis operator proposing the acquisition.
- CompanyAurora Cannabis
Canadian cannabis producer and acquisition target.

